Tumor-on-a-Chip Reveals How Pancreatic Cancer Hijacks Immune Cells
Researchers have developed a 'tumor-on-a-chip' micro-engineered model to observe how pancreatic cancer cells interact with the immune system in real time. This technology reveals how tumors create a protective environment, offering potential new targets for more effective cancer therapies.
Why it matters
Pancreatic cancer is highly lethal, and this breakthrough in modeling could lead to significant advancements in treatment efficacy and early diagnosis.
Using a micro-engineered “tumor-on-a-chip” model, Sylvester researchers recreated the complex ecosystem surrounding pancreatic tumors and observed how cells interact dynamically. The findings reveal a critical mechanism that may explain why many therapies fail and point to new therapeutic strategies.
The report is a straightforward summary of scientific research findings without subjective commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in